LANEKA RAISON: Open Payments
NPI 1194508705 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28 in 2 payments from 2 companies in 2025. Trend: 2023 $24 · 2024 $111 · 2025 $28
Food & beverage: $25Education: $2
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: TARPEYO, Filspari.
Industry payments across PA — which companies pay providers there.
